BE528813A - - Google Patents
Info
- Publication number
- BE528813A BE528813A BE528813DA BE528813A BE 528813 A BE528813 A BE 528813A BE 528813D A BE528813D A BE 528813DA BE 528813 A BE528813 A BE 528813A
- Authority
- BE
- Belgium
- Prior art keywords
- acid
- salts
- converted
- mercapto
- triazine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 230000000875 corresponding Effects 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- BRWIZMBXBAOCCF-UHFFFAOYSA-N aminothiourea Chemical compound NNC(N)=S BRWIZMBXBAOCCF-UHFFFAOYSA-N 0.000 claims description 3
- 229940042396 direct acting antivirals Thiosemicarbazones Drugs 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 150000007857 hydrazones Chemical class 0.000 claims description 3
- 150000007529 inorganic bases Chemical class 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 150000003584 thiosemicarbazones Chemical class 0.000 claims description 3
- 201000008827 tuberculosis Diseases 0.000 claims description 3
- 201000009910 diseases by infectious agent Diseases 0.000 claims description 2
- GVCGWXSZNUOTDW-UHFFFAOYSA-N sulfo cyanate Chemical compound OS(=O)(=O)OC#N GVCGWXSZNUOTDW-UHFFFAOYSA-N 0.000 claims description 2
- FHNYFUNJQHPHAC-UHFFFAOYSA-N 2H-triazin-5-one Chemical compound OC1=CN=NN=C1 FHNYFUNJQHPHAC-UHFFFAOYSA-N 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000006011 modification reaction Methods 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000002923 oximes Chemical class 0.000 description 4
- 230000001549 tubercolostatic Effects 0.000 description 4
- 241000208818 Helianthus Species 0.000 description 3
- 235000003222 Helianthus annuus Nutrition 0.000 description 3
- QRXWMOHMRWLFEY-UHFFFAOYSA-N Isoniazid Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 3
- 125000005907 alkyl ester group Chemical group 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229960003116 Amyl Nitrite Drugs 0.000 description 2
- CSDTZUBPSYWZDX-UHFFFAOYSA-N Amyl nitrite Chemical compound CCCCCON=O CSDTZUBPSYWZDX-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 230000001225 therapeutic Effects 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N D-Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- TWBYWOBDOCUKOW-UHFFFAOYSA-N Isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-UUNJERMWSA-N Lactose Natural products O([C@@H]1[C@H](O)[C@H](O)[C@H](O)O[C@@H]1CO)[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1 GUBGYTABKSRVRQ-UUNJERMWSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- -1 alcoholates Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- KFUSANSHCADHNJ-UHFFFAOYSA-N pyridine-3-carbohydrazide Chemical compound NNC(=O)C1=CC=CN=C1 KFUSANSHCADHNJ-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE528813A true BE528813A (es) |
Family
ID=162010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE528813D BE528813A (es) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE528813A (es) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1190947B (de) * | 1961-04-28 | 1965-04-15 | Hoechst Ag | Verfahren zur Herstellung von tuberculostatisch wirksamen alkylierten asymmetrischen 3-Imino-triazin-Derivaten |
-
0
- BE BE528813D patent/BE528813A/fr unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1190947B (de) * | 1961-04-28 | 1965-04-15 | Hoechst Ag | Verfahren zur Herstellung von tuberculostatisch wirksamen alkylierten asymmetrischen 3-Imino-triazin-Derivaten |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0092459A2 (fr) | Imidazo(1,2-a)pyridines, leur préparation et leur application en thérapeutique | |
| EP1023277A1 (fr) | Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique | |
| EP0306408A1 (fr) | Imidazo[1,2b]pyridazines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| WO1991019714A1 (fr) | Nouveaux derives de l'oxazole, leur preparation et les compositions pharmaceutiques qui les contiennent | |
| BE528813A (es) | ||
| CH407088A (fr) | Procédé de préparation de dérivés des acides 4-halo-3-sulfamoyl-benzoïques | |
| EP0000452B1 (fr) | Dérivés d'oxadiazole-1,2,4, leur préparation et leur application en thérapeutique. | |
| FR2566774A1 (fr) | Derives de 5h-2,3-benzodiazepine, leur procede de preparation et compositions pharmaceutiques les contenant | |
| FR2529891A1 (fr) | Derives du pyridyl-3 alcoxy-5 pyrazole, procede de preparation et application en therapeutique | |
| WO1992021664A1 (fr) | Nouveaux derives de l'oxazole, leur preparation et les compositions qui les contiennent | |
| BE897845A (fr) | B-oxo-x-carbamoyl-pyrrolptropionitriles, procede pour leur preparation preparations pharmaceutiques contenant ces composes ainsi que leur application | |
| EP0183577A1 (fr) | Dérivés du thiadiazole actifs sur le système nerveux central, procédé d'obtension et compositions pharmaceutiques les contenant | |
| WO1992021665A1 (fr) | Nouveaux derives de l'oxazole et leur preparation | |
| CH529153A (fr) | Procédé de préparation de pyrazolo (1,2-b) phtalazine-1,5 (10H)-diones | |
| EP0161235A2 (fr) | Nouveaux dérivés de thiénopyridinone, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| CH645115A5 (fr) | Procede pour preparer la chloro-7 methyl-2 dihydro-3,3a 2h,9h-isoxazolo(3,2-b)(benzoxazine-1,3)one-9. | |
| CH635590A5 (fr) | Derives de l'isoquinoleine, leur preparation et compositions pharmaceutiques qui les contiennent. | |
| BE897146A (fr) | Derives d'acide apovincaminique, procede pour leur preparation et compositions pharmaceutiques contenant ces derives | |
| FR2665442A1 (fr) | Derives d'alkyl-6 pyridazine, procede de preparation et compositions pharmaceutiques en contenant. | |
| BE528490A (es) | ||
| BE531615A (es) | ||
| CA2022460A1 (fr) | Derives benzothiaziniques, leur preparation et leurs applications comme medicaments ou comme intermediaires de synthese de medicaments | |
| BE896159A (fr) | 1h-pyrazolo (1,5,-a) pyrimidines substituees et leur preparation | |
| WO1995000513A1 (fr) | Naphtyridines antiproliferatives | |
| LU81891A1 (fr) | Derives d'amino-3 dioxo-2,4(1h,3h)quinazolines,leur procede de preparation et composition therapeutique les contenant |